182 related articles for article (PubMed ID: 17591970)
1. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.
Lee S; Medina D; Tsimelzon A; Mohsin SK; Mao S; Wu Y; Allred DC
Am J Pathol; 2007 Jul; 171(1):252-62. PubMed ID: 17591970
[TBL] [Abstract][Full Text] [Related]
2. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.
Lee S; Mohsin SK; Mao S; Hilsenbeck SG; Medina D; Allred DC
Breast Cancer Res; 2006; 8(1):R6. PubMed ID: 16417654
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell identity in hyperplastic precursors of breast cancer.
Coradini D; Boracchi P; Oriana S; Biganzoli E; Ambrogi F
Chin J Cancer; 2015 Mar; 34(3):121-9. PubMed ID: 25962646
[TBL] [Abstract][Full Text] [Related]
4. Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.
Björner S; Fitzpatrick PA; Li Y; Allred C; Howell A; Ringberg A; Olsson H; Miller CJ; Axelson H; Landberg G
PLoS One; 2014; 9(8):e105099. PubMed ID: 25122196
[TBL] [Abstract][Full Text] [Related]
5. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients.
Tripathi A; King C; de la Morenas A; Perry VK; Burke B; Antoine GA; Hirsch EF; Kavanah M; Mendez J; Stone M; Gerry NP; Lenburg ME; Rosenberg CL
Int J Cancer; 2008 Apr; 122(7):1557-66. PubMed ID: 18058819
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
[TBL] [Abstract][Full Text] [Related]
7. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast.
Diallo R; Schaefer KL; Poremba C; Shivazi N; Willmann V; Buerger H; Dockhorn-Dworniczak B; Boecker W
J Pathol; 2001 Jan; 193(1):27-32. PubMed ID: 11169512
[TBL] [Abstract][Full Text] [Related]
8. Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization.
Meng ZH; Ben Y; Li Z; Chew K; Ljung BM; Lagios MD; Dairkee SH
Genes Chromosomes Cancer; 2004 Nov; 41(3):214-22. PubMed ID: 15334544
[TBL] [Abstract][Full Text] [Related]
9. Molecular and genetic abnormalities in radial scar.
Iqbal M; Shoker BS; Foster CS; Jarvis C; Sibson DR; Davies MP
Hum Pathol; 2002 Jul; 33(7):715-22. PubMed ID: 12196923
[TBL] [Abstract][Full Text] [Related]
10. Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.
Rosenberg CL; de las Morenas A; Huang K; Cupples LA; Faller DV; Larson PS
J Clin Invest; 1996 Sep; 98(5):1095-100. PubMed ID: 8787670
[TBL] [Abstract][Full Text] [Related]
11. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
12. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
13. Cell identity disruption in breast cancer precursors.
Coradini D; Boracchi P; Oriana S; Biganzoli E; Ambrogi F
Anticancer Res; 2014 Mar; 34(3):1307-19. PubMed ID: 24596378
[TBL] [Abstract][Full Text] [Related]
14. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Fuqua SA; Wiltschke C; Zhang QX; Borg A; Castles CG; Friedrichs WE; Hopp T; Hilsenbeck S; Mohsin S; O'Connell P; Allred DC
Cancer Res; 2000 Aug; 60(15):4026-9. PubMed ID: 10945602
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.
Ellsworth RE; Ellsworth DL; Weyandt JD; Fantacone-Campbell JL; Deyarmin B; Hooke JA; Shriver CD
Ann Surg Oncol; 2010 Jun; 17(6):1688-94. PubMed ID: 20107913
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of histologically normal breast tissue in females with human epidermal growth factor receptor 2‑positive breast cancer.
Zubor P; Hatok J; Moricova P; Kapustova I; Kajo K; Mendelova A; Sivonova MK; Danko J
Mol Med Rep; 2015 Feb; 11(2):1421-7. PubMed ID: 25373323
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed genes associated with hormones in terminal ductal lobular units identified by global transcriptome analysis: An insight into the anatomic origin of breast cancer.
Yang J; Yu H; Zhang L; Deng H; Wang Q; Li W; Zhang A; Gao H; Yin A
Oncol Rep; 2016 Mar; 35(3):1689-95. PubMed ID: 26707748
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
20. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
